Latest News of CNS
Sanofi gains exclusivity rights to Ventyx's CNS-penetrant drug in $27m deal
By Yahoo! Finance |
5 days ago
Sanofi secures exclusive rights to Ventyx Biosciences' CNS-penetrant candidate VTX3232 in a $27 million deal. This agreement grants Sanofi first negotiation rights for the potential neuroinflammatory ...
Stocks Showing Improving Market Leadership: Reynolds Cnsmr Products Earns 84 RS Rating
By Investor's Business Daily |
3 weeks ago
IBD's RS Rating helps identify market leaders by comparing a stock's price movement against others. Look for stocks with RS Rating above 80 in early stages for potential winners. Focus on factors like...
Reynolds Cnsmr Products Sees IBD RS Rating Improve To 71
By Investor's Business Daily |
1 month ago
Institutional support is crucial for stock performance. IBD's RS Rating measures a stock's technical performance over 52 weeks. Reynolds Consumer Products should show strength above 80 for potential g...
-
Director Richard Simon Sells 7,000 Shares of Cohen & Steers Inc (CNS)
By Yahoo! Finance | 2 months agoCohen & Steers Inc specializes in real assets investment strategies for income and wealth preservation. Recent insider sells show a trend of 7 sells and no buys in the past year, with shares considere...
-
Cohen & Steers Inc (CNS) Stock Forecasts
By Yahoo! Finance | 3 months agoCohen & Steers specializes in real estate securities and manages $80.5 billion in assets. They invest in real estate investment trusts globally and also handle preferred securities, utilities stocks, ...